Metropolitan Life Insurance Co. NY Has $218,000 Holdings in Phibro Animal Health (PAHC)

Metropolitan Life Insurance Co. NY lessened its stake in shares of Phibro Animal Health (NASDAQ:PAHC) by 53.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,518 shares of the company’s stock after selling 7,479 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Phibro Animal Health were worth $218,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Goldman Sachs Group Inc. grew its holdings in Phibro Animal Health by 17.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock valued at $15,959,000 after purchasing an additional 69,063 shares during the last quarter. California Public Employees Retirement System grew its holdings in Phibro Animal Health by 9.5% during the third quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock valued at $1,667,000 after purchasing an additional 3,894 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in Phibro Animal Health by 37.4% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock valued at $8,159,000 after purchasing an additional 66,300 shares during the last quarter. Investors Research Corp acquired a new position in Phibro Animal Health during the fourth quarter valued at approximately $433,000. Finally, Spark Investment Management LLC grew its holdings in Phibro Animal Health by 129.5% during the fourth quarter. Spark Investment Management LLC now owns 47,500 shares of the company’s stock valued at $1,591,000 after purchasing an additional 26,800 shares during the last quarter. Institutional investors own 48.14% of the company’s stock.

In other news, CEO Jack Bendheim sold 2,802 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $38.01, for a total value of $106,504.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Larry Lee Miller sold 54,572 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $35.36, for a total value of $1,929,665.92. Following the completion of the sale, the chief operating officer now directly owns 8,582 shares of the company’s stock, valued at $303,459.52. The disclosure for this sale can be found here. Insiders sold 276,056 shares of company stock valued at $10,495,260 over the last three months. 51.88% of the stock is owned by company insiders.

PAHC opened at $43.00 on Thursday. Phibro Animal Health has a 1-year low of $28.60 and a 1-year high of $44.55. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.75. The company has a market capitalization of $1,736.25, a PE ratio of 28.48, a price-to-earnings-growth ratio of 3.06 and a beta of 0.93.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Monday, February 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.06. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The company had revenue of $205.90 million during the quarter, compared to analysts’ expectations of $194.90 million. During the same period in the prior year, the business earned $0.39 earnings per share. Phibro Animal Health’s revenue for the quarter was up 7.5% compared to the same quarter last year. sell-side analysts predict that Phibro Animal Health will post 1.69 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th were given a $0.10 dividend. The ex-dividend date of this dividend was Tuesday, March 6th. This represents a $0.40 annualized dividend and a dividend yield of 0.93%. Phibro Animal Health’s dividend payout ratio is 26.49%.

Several equities analysts have commented on the company. Zacks Investment Research downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Wednesday, April 11th. BidaskClub upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Wednesday, April 18th. Credit Suisse Group increased their price target on Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a report on Tuesday, February 6th. Morgan Stanley increased their price target on Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a report on Wednesday, February 7th. Finally, ValuEngine upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Wednesday, February 28th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $38.20.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.thestockobserver.com/2018/04/26/metropolitan-life-insurance-co-ny-has-218000-holdings-in-phibro-animal-health-pahc.html.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply